Trial Condition(s):

Pityriasis versicolor

BAY H 4502 cream 2.5% with two different treatment schedules in Pityriasis versicolor

Bayer Identifier:

Trial_0448

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
60
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Mycospor/Canesten Extra (Bifonazole, BAYH4502)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

For details, please refer to trial results

Additional Information

Not Available